Advanced Medicine

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

Intellegens CEO Ben Pellegrini explains how machine learning is set to change the oligonucleotide manufacturing landscape

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

After serving as Head of Research Development at Trinity College Dublin, Fiona Killard-Lynch became Director of Research and Innovation at NIBRT

How a three-way collaboration aims to use digital twins to refine the efficiency of adeno-associated virus manufacture

AskBio CEO Sheila Mikhail shares the story behind her success and her strength

The importance of experience, learning, collaboration, and dealing with environments dominated by men

Experts suggest that outsourcing CGT manufacturing capabilities to CDMOs brings additional benefits, although not without challenges

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301